Viatris Inc
22 FDA enforcement actions
22 Total Recalls
1 Class I
20 Class II
1 Class III
Firm Details
- Product Types
- drug
- States
- PA
All Recalls
- Class II: Risk 12/23/2024 drug
- Class II: Risk 12/23/2024 drug
- Class II: Risk 11/18/2024 drug
- Class II: Risk 11/18/2024 drug
- Class II: Risk 11/18/2024 drug
- Class II: Risk 11/18/2024 drug
- Class II: Risk 11/18/2024 drug
- Class II: Risk 11/18/2024 drug
- Class II: Risk 11/18/2024 drug
- Class II: Risk 11/18/2024 drug
- Class II: Risk 11/18/2024 drug
- Class II: Risk 11/18/2024 drug
- Class II: Risk 11/18/2024 drug
- Class II: Risk 04/30/2024 drug
- Class II: Risk 04/30/2024 drug
- Class III: Low Risk 04/25/2024 drug
- Class II: Risk 05/25/2023 drug
- Class II: Risk 10/21/2022 drug
- Class I: Dangerous 10/07/2022 drug
- Class II: Risk 09/21/2022 drug
- Class II: Risk 04/28/2022 drug
- Class II: Risk 04/28/2022 drug
Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.